Joshua McElwee

Joshua McElwee has over 15 years of experience in pharmaceutical research and leadership. Joshua is currently the Founder and Principal of JJM Bioconsulting, providing guidance on genetic and genomic strategies. Joshua was previously the Executive Director of Discovery Biology at Nimbus Therapeutics, focusing on new target discovery and program development. Prior to that, Joshua held various roles at Merck, including Director of Immunogenetics, where Joshua focused on identifying novel targets for immunological indications. Joshua holds a PhD in Molecular and Cellular Biology from the University of Washington and a BA in Molecular and Cellular Biology from the University of Colorado Boulder.